Clinical Trials Arena is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

NURTEC (Rimegepant) for the Acute Treatment of Migraine

Drug (Brand/Generic)

NURTECTM (Rimegepant)

Developer

Biohaven Pharmaceuticals

Product Description

Orally disintegrating tablet (ODT)

Therapy Class

Calcitonin gene-related peptide receptor antagonist

Current Indication

Migraine

Market Sector

Central nervous system (CNS)

Development Status

Approved in the US
Expand
Close
Close
Close

Go Top